Literature DB >> 15857357

Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?

H J Longhurst1.   

Abstract

Hereditary angioedema (HAE) is caused by a deficiency in C1 esterase-inhibitor (C1-INH) and is characterised by skin swelling, abdominal pain and episodes of upper respiratory tract obstruction. Oedema of the larynx can result in rapid asphyxiation and requires emergency treatment. Three treatment options for emergency treatment of HAE are reviewed: fresh frozen plasma, solvent/detergent-treated plasma and C1-INH concentrate. It is concluded that while all three treatment options are theoretically effective in the emergency treatment of HAE, C1-INH is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857357     DOI: 10.1111/j.1742-1241.2005.00352.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  18 in total

Review 1.  Management of acute attacks of hereditary angioedema: potential role of icatibant.

Authors:  Hilary J Longhurst
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

2.  Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema.

Authors:  Timothy J Craig; Richard L Wasserman; Robyn J Levy; Againdra K Bewtra; Lynda Schneider; Flint Packer; William H Yang; Heinz-Otto Keinecke; Peter C Kiessling
Journal:  J Clin Immunol       Date:  2010-07-16       Impact factor: 8.317

Review 3.  Current and emerging management options for hereditary angioedema in the US.

Authors:  Tolly G Epstein; Jonathan A Bernstein
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

5.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema.

Authors:  M D Tarzi; A Hickey; T Förster; M Mohammadi; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

Review 6.  C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?

Authors:  R J Lock; M M Gompels
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

7.  Icatibant.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2010       Impact factor: 9.546

8.  Conestat alfa for the treatment of angioedema attacks.

Authors:  Benjamin Davis; Jonathan A Bernstein
Journal:  Ther Clin Risk Manag       Date:  2011-07-01       Impact factor: 2.423

9.  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Authors:  Marcus Maurer; Markus Magerl; Stephen Betschel; Werner Aberer; Ignacio J Ansotegui; Emel Aygören-Pürsün; Aleena Banerji; Noémi-Anna Bara; Isabelle Boccon-Gibod; Konrad Bork; Laurence Bouillet; Henrik Balle Boysen; Nicholas Brodszki; Paula J Busse; Anette Bygum; Teresa Caballero; Mauro Cancian; Anthony J Castaldo; Danny M Cohn; Dorottya Csuka; Henriette Farkas; Mark Gompels; Richard Gower; Anete S Grumach; Guillermo Guidos-Fogelbach; Michihiro Hide; Hye-Ryun Kang; Allen P Kaplan; Constance H Katelaris; Sorena Kiani-Alikhan; Wei-Te Lei; Richard F Lockey; Hilary Longhurst; William Lumry; Andrew MacGinnitie; Alejandro Malbran; Inmaculada Martinez Saguer; Juan José Matta Campos; Alexander Nast; Dinh Nguyen; Sandra A Nieto-Martinez; Ruby Pawankar; Jonathan Peter; Grzegorz Porebski; Nieves Prior; Avner Reshef; Marc Riedl; Bruce Ritchie; Farrukh Rafique Sheikh; William B Smith; Peter J Spaeth; Marcin Stobiecki; Elias Toubi; Lilian Agnes Varga; Karsten Weller; Andrea Zanichelli; Yuxiang Zhi; Bruce Zuraw; Timothy Craig
Journal:  World Allergy Organ J       Date:  2022-04-07       Impact factor: 5.516

Review 10.  Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema.

Authors:  Ankur Kumar Jindal; Avner Reshef; Hilary Longhurst
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-18       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.